DE60227549D1 - Verwendung von leptin bei unfruchtbarkeit - Google Patents

Verwendung von leptin bei unfruchtbarkeit

Info

Publication number
DE60227549D1
DE60227549D1 DE60227549T DE60227549T DE60227549D1 DE 60227549 D1 DE60227549 D1 DE 60227549D1 DE 60227549 T DE60227549 T DE 60227549T DE 60227549 T DE60227549 T DE 60227549T DE 60227549 D1 DE60227549 D1 DE 60227549D1
Authority
DE
Germany
Prior art keywords
barreness
leptin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60227549T
Other languages
English (en)
Inventor
Dalit Barkan
Nava Dekel
Menachem Rubinstein
Vladimir Hurgin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Application granted granted Critical
Publication of DE60227549D1 publication Critical patent/DE60227549D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60227549T 2001-11-21 2002-11-21 Verwendung von leptin bei unfruchtbarkeit Expired - Lifetime DE60227549D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL14665501A IL146655A0 (en) 2001-11-21 2001-11-21 The use of leptin in fertility
PCT/IL2002/000928 WO2003043652A2 (en) 2001-11-21 2002-11-21 The use of leptin in fertility

Publications (1)

Publication Number Publication Date
DE60227549D1 true DE60227549D1 (de) 2008-08-21

Family

ID=11075871

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60227549T Expired - Lifetime DE60227549D1 (de) 2001-11-21 2002-11-21 Verwendung von leptin bei unfruchtbarkeit

Country Status (12)

Country Link
US (1) US20050065080A1 (de)
EP (1) EP1446144B1 (de)
JP (1) JP2005509664A (de)
AR (1) AR037671A1 (de)
AT (1) ATE400292T1 (de)
AU (1) AU2002353464B2 (de)
CA (1) CA2467536A1 (de)
DE (1) DE60227549D1 (de)
DK (1) DK1446144T3 (de)
ES (1) ES2305327T3 (de)
IL (1) IL146655A0 (de)
WO (1) WO2003043652A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007025349A1 (en) * 2005-09-01 2007-03-08 The University Of New England Modulating ovulation and growth rates
WO2019122153A2 (en) * 2017-12-21 2019-06-27 Aarhus Universitet Compounds for use in regulating follicle maturation
US20230044690A1 (en) * 2019-12-23 2023-02-09 Augusta University Research Institute, Inc. Progesterone formulation to trigger ovulation and provide luteal phase support

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998036763A1 (en) * 1997-02-25 1998-08-27 Eli Lilly And Company Treatment of infertility with leptin receptor ligands

Also Published As

Publication number Publication date
WO2003043652A3 (en) 2004-03-18
JP2005509664A (ja) 2005-04-14
AU2002353464B2 (en) 2007-01-18
ATE400292T1 (de) 2008-07-15
EP1446144B1 (de) 2008-07-09
WO2003043652A2 (en) 2003-05-30
US20050065080A1 (en) 2005-03-24
EP1446144A2 (de) 2004-08-18
DK1446144T3 (da) 2008-08-25
CA2467536A1 (en) 2003-05-30
AR037671A1 (es) 2004-12-01
ES2305327T3 (es) 2008-11-01
AU2002353464A1 (en) 2003-06-10
IL146655A0 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
DE60144013D1 (de) Harzzusammensetzung und verwendung derselben
DE50115561D1 (de) Spektralphotometer und Verwendung desselben
DE50212455D1 (de) Verwendung von Dimerdiolen
DE60208661D1 (de) Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren
NO20040469L (no) Heterocykliske forbindelser samt fremstilling og anvendelse derav
ATE533508T1 (de) Cripto-blockierende antikörper und ihre verwendung
DE60209486D1 (de) Pyranoindazole und ihre verwendung in der glaukombehandlung
DE02784674T1 (de) Quantifizierung von polypeptiden
ATE456657T1 (de) Aromatische methyltransferasen und ihre verwendung
DE60230883D1 (de) Neue formulierungen und ihre verwendung
DE50110553D1 (de) Verwendung herbizider Mittel
DE50206094D1 (de) Substituierte isoindole und ihre verwendung
DE502004011575D1 (de) Verwendung von Dioldimerfettsäureestern
DE60230162D1 (de) Polymerisate und ihre verwendung
DE60102122D1 (de) Zusammensetzung von Poly-1-Butenharz und dessen Verwendung
DE60322926D1 (de) Photopolymerisierbare zusammensetzung und verwendung davon
DE50311406D1 (de) Verwendung von Formkörpern
DE60007360T2 (de) Amorphe modifikation von torasemid
DE60227549D1 (de) Verwendung von leptin bei unfruchtbarkeit
ATE299873T1 (de) Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate
DE60229367D1 (de) Leiterzusammensetzungen und verwendung derselben
ATE431144T1 (de) Neue formulierungen und ihre verwendung
ATE347544T1 (de) Substituierte phenylcyclohexancarbonsäureamide und ihre verwendung
ATA2152001A (de) Verwendung von selenhältigen präparaten
DE60221331D1 (de) Verwendung von 4-Ethyloctanal in Riech- und Geschmackzusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition